SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
-12.1%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$371M
AUM Growth
+$371M
(-33%)
Cap. Flow
-$76.3M
Cap. Flow
% of AUM
-20.55%
Top 10 Holdings %
Top 10 Hldgs %
58.47%
Holding
138
New
19
Increased
20
Reduced
26
Closed
49
Top Buys
| 1 |
Viatris
VTRS
|
$13.3M |
| 2 |
SHPG
Shire pic
SHPG
|
$13M |
| 3 |
Ituran Location and Control
ITRN
|
$9.28M |
| 4 |
Pfizer
PFE
|
$7.41M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$4.33M |
Top Sells
| 1 |
AbbVie
ABBV
|
$21.4M |
| 2 |
Bristol-Myers Squibb
BMY
|
$8.36M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$6.09M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$5.76M |
| 5 |
Incyte
INCY
|
$5.6M |
Sector Composition
| 1 | Healthcare | 77.34% |
| 2 | Technology | 4.69% |
| 3 | Utilities | 3.59% |
| 4 | Communication Services | 2.82% |
| 5 | Financials | 1.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Rocket Pharmaceuticals
RCKT
$359M
| $1.85M | 0.4% |
250,000
-110,000
| -31% | -$814K |
|
|
RPTP
52
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $1.84M | 0.4% |
400,000
-285,000
| -42% | -$1.31M |
|
|
CLVS
53
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.81M | 0.39% |
94,500
| – | – |
|
54
Bausch Health
BHC
$2.73B
| $1.8M | 0.39% |
68,500
+34,750
| +103% | +$914K |
|
55
Nice
NICE
$8.45B
| $1.77M | 0.38% |
+27,300
| New | +$1.77M |
|
|
CLCD
56
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
| $1.73M | 0.37% |
278,337
-7,188
| -3% | -$44.6K |
|
57
Wabtec
WAB
$32.6B
| $1.72M | 0.37% |
21,704
+8,943
| +70% | +$709K |
|
58
Ionis Pharmaceuticals
IONS
$9.64B
| $1.62M | 0.35% |
40,000
-41,200
| -51% | -$1.67M |
|
59
PTC Therapeutics
PTCT
$4.38B
| $1.61M | 0.35% |
250,000
+183,980
| +279% | +$1.18M |
|
60
Corvus Pharmaceuticals
CRVS
$437M
| $1.61M | 0.35% |
+110,921
| New | +$1.61M |
|
|
CYNA
61
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $1.6M | 0.35% |
134,037
| – | – |
|
|
ORBK
62
DELISTED
Orbotech Ltd
ORBK
| $1.56M | 0.34% |
65,710
-101,909
| -61% | -$2.42M |
|
|
PVLA
63
Palvella Therapeutics, Inc. Common Stock
PVLA
$568M
| $1.54M | 0.33% |
810,000
| – | – |
|
|
ALDR
64
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $1.53M | 0.33% |
62,500
-50,000
| -44% | -$1.22M |
|
65
Summit Therapeutics
SMMT
$17.3B
| $1.39M | 0.3% |
198,863
-3,357
| -2% | -$23.5K |
|
66
PDS Biotechnology
PDSB
$60.2M
| $1.37M | 0.3% |
150,000
-5,000
| -3% | -$45.8K |
|
|
BLUE
67
DELISTED
bluebird bio
BLUE
| $1.28M | 0.28% |
+30,000
| New | +$1.28M |
|
68
SCYNEXIS
SCYX
$34.1M
| $1.23M | 0.27% |
304,600
| – | – |
|
|
TRIL
69
DELISTED
Trillium Therapeutics Inc.
TRIL
| $1.22M | 0.27% |
132,300
| – | – |
|
|
PTN
70
DELISTED
Palatin Technologies
PTN
| $1.22M | 0.27% |
2,264,426
-868,500
| -28% | -$469K |
|
71
Abeona Therapeutics
ABEO
$352M
| $1.2M | 0.26% |
468,050
-131,950
| -22% | -$338K |
|
72
Astria Therapeutics
ATXS
$384M
| $1.16M | 0.25% |
230,041
+149,299
| +185% | +$752K |
|
73
Catalyst Pharmaceutical
CPRX
$2.43B
| $1.06M | 0.23% |
905,000
-550,000
| -38% | -$644K |
|
|
PTLA
74
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.02M | 0.22% |
50,000
-35,500
| -42% | -$724K |
|
75
Aldeyra Therapeutics
ALDX
$349M
| $999K | 0.22% |
238,500
| – | – |
|